Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Kevin Deane MD, PhD

Kevin D. Deane MD, PhD

Professor of Medicine, Division of Rheumatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA

Dr. Deane is a Rheumatologist and Professor of Medicine at the University of Colorado. His research interests are in understanding how rheumatoid arthritis (RA) develops, and especially the biology of RA prior to the onset of the first swollen joint – a period that can be termed ‘pre-RA’. In addition, he is interested in identifying ways to prevent future RA, and as part of these efforts he is the principal investigator on the NIH-sponsored StopRA study which is evaluating the role of hydroxychloroquine to prevent or delay the onset of arthritis in individuals who have high-risk autoantibody biomarkers for future RA.

Disclosures

Dr. Deane has no relevant disclosures.